We are live on ! Find out more
BME icon

BlackRock Health Sciences Trust

26 hedge funds and large institutions have $55M invested in BlackRock Health Sciences Trust in 2014 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $56.8M → $55M (-$1.82M)

1.52% less ownership

Funds ownership: 20.06%18.54% (-1.5%)

19% less funds holding

Funds holding: 3226 (-6)

55% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 11

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
26
Holders Change
-6
Holders Change %
-18.75%
% of All Funds
0.75%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
5
Reduced
11
Closed
6
Calls
Puts
Net Calls
Net Calls Change

BME Hedge Fund Activity: Q1 2014 in Review

26 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in BlackRock Health Sciences Trust (BME) for Q1 2014, worth a combined $55M — down 3.2% from $56.8M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of BME and 1 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 5 added.

The largest buyer was Bank of America, adding an estimated $263K. The largest seller was Morgan Stanley, cutting an estimated $1.39M.

  • 26 institutional investors held BlackRock Health Sciences Trust (BME) as of Q1 2014, down from 32 in Q4 2013.
  • Funds reported $55M of BlackRock Health Sciences Trust stock for Q1 2014, down 3.2% quarter-over-quarter.
  • 1 fund opened new BlackRock Health Sciences Trust positions in Q1 2014 and 6 closed out, a net change of -5 holders.
  • The largest BlackRock Health Sciences Trust buyer in Q1 2014 was Bank of America, an estimated $263K added.
  • The largest BlackRock Health Sciences Trust seller in Q1 2014 was Morgan Stanley, an estimated $1.39M sold.

Based on aggregated 13F filings for Q1 2014.